Efficacy and Safety of Dingkundan Combined With Combination Oral Contraceptives in the Treatment of PCOS

NACompletedINTERVENTIONAL
Enrollment

120

Participants

Timeline

Start Date

February 1, 2023

Primary Completion Date

April 1, 2024

Study Completion Date

April 1, 2024

Conditions
PCOS
Interventions
DRUG

DingKunDan(GuangYuYuan)

"The experimental group would be given DingKunDan, the subjects should take 3.5g each time, twice a day.~Subjects in the control group only needed to take COC. Both groups take medicine for 3 months consecutively as a course of treatment."

DRUG

Drospirenone and Ethinylestradiol Tablets (Ⅱ)

The experimental group and the control group would be given oral Drospirenone and Ethinylestradiol Tablets (Ⅱ). According to the packaging instructions, on the first day of menstruation, according to the packaging instructions, the subjects should take the tablet, then take the rest sequential at the same time every day for 28 consecutive days, menstruation would happen after drug withdrawal (or after 7 days of drug withdrawal), and the next medication cycle begin on the first day of menstruation.

Trial Locations (1)

Unknown

Guangdong Women and Children Health Hospital, Guangzhou

All Listed Sponsors
lead

Guangdong Women and Children Hospital

OTHER